Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 1/20 | 0.34 |
| ▸ | PIP4K2A | P48426 | 4/20 | 0.33 |
| ▸ | PIP4K2B | P78356 | 4/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.30 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.30 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2127929 | 1.00 | CYP3A4 (0.55) | CYP3A4KIF11TDP2PIP4K2APIP4K2B | |
| SCHEMBL2127309 | 0.92 | CYP3A4 (0.53) | CYP3A4TDP2PIP4K2APIP4K2BPIP4K2C | |
| SCHEMBL1543093 | 0.92 | CYP3A4 (0.53) | CYP3A4TDP2PIP4K2APIP4K2BPIP4K2C | |
| SCHEMBL2129635 | 0.88 | CYP3A4 (0.53) | CYP3A4KIF11TDP2PIP4K2APIP4K2B | |
| SCHEMBL1542785 | 0.88 | CYP3A4 (0.53) | CYP3A4KIF11TDP2PIP4K2APIP4K2B | |
| SCHEMBL2128358 | 0.88 | CYP3A4 (0.71) | CYP3A4TDP2PIP4K2APIP4K2BTRPV1 | |
| SCHEMBL1542500 | 0.88 | CYP3A4 (0.71) | CYP3A4TDP2PIP4K2APIP4K2BTRPV1 | |
| SCHEMBL1542622 | 0.84 | CYP3A4 (0.53) | CYP3A4KIF11TDP2PIP4K2APIP4K2B | |
| SCHEMBL2127454 | 0.84 | CYP3A4 (0.55) | CYP3A4KIF11TDP2PIP4K2APIP4K2B | |
| SCHEMBL1542215 | 0.84 | CYP3A4 (0.55) | CYP3A4KIF11TDP2PIP4K2APIP4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307372-B1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2012-04-25 | — | — | EP | claimed |
| EP-2307372-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2011-04-13 | — | — | EP | claimed |
| WO-2010010017-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-01-28 | — | — | WO | claimed |
| US-20100021423-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2010-01-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021423-A1 | Heterocyclic antiviral compounds | POLR2A, RRM2B, RRP1B | CYP3A4 528/4885KIF11 4398/4885TDP2 3997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.